Vetoquinol - Universal Registration Document - 2021

CONSOLIDATED FINANCIAL STATEMENTS Notes to the consolidated financial statements 90 Vetoquinol Universal Registration Document 2020 Financial report 6 6.5.21 Intangible assets €000 Concessions, licensing and patents Computer programs Trademarks Other intangible Assets incl. Products- Proprietary Total AT DECEMBER 31, 2018 GROSS BOOK VALUE 22,848 19,740 13,426 54,214 110,228 ACCUMULATED DEPRECIATION (15,032) (14,896) (1,983) (35,439) (67,350) NET BOOK VALUE 7,815 4,844 11,444 18,775 42,878 Acquisitions 3,447 2,430 - 19 5,896 Acquisitions through business combinations 97 2,787 - - 2,884 Change in consolidation method - - - - - Disposals (net book value) (3,968) (74) - - (4,041) Reclassifications - (19) 1,989 (1,989) (19) Depreciation and amortization (735) (1,670) (994) (1,597) (4,997) Deconsolidation - - - - - Exchange differences, net 3 87 (67) 327 350 AT DECEMBER 31, 2019 GROSS BOOK VALUE 22,387 22,991 13,406 52,459 111,244 ACCUMULATED DEPRECIATION (15,728) (14,607) (1,035) (36,924) (68,294) NET BOOK VALUE 6,659 8,384 12,371 15,536 42,950 Acquisitions 135 3,692 6,633 123,775 134,235 Acquisitions through business combinations - - - (0) (0) Purchase price allocation - asset recognition - - - 17,913 17,913 Change in consolidation method - - - (0) (0) Disposals (net book value) - (483) (0) (408) (890) Reclassifications (1,873) (55) 975 831 (122) Depreciation and amortization (711) (1,734) - (8,672) (11,118) Deconsolidation - - - - - Exchange differences, net (150) (187) (461) (7,177) (7,975) AT DECEMBRE 31, 2020 GROSS BOOK VALUE 20,086 25,262 19,565 185,437 250,349 ACCUMULATED DEPRECIATION (16,027) (15,644) (47) (43,639) (75,356) NET BOOK VALUE 4,060 9,617 19,518 141,798 174,993 At the end of December 2020, the “Trademarks” column includes the following: • the Equistro trademark valued at €8,9 million, which has an indefinite life and, as such, is not amortized; • the Drontal ® and Profender ® trademarks, valued at €6.6 million; • other trademarks (around 40, valued at €4.0 million) were recognized at the 2009 acquisition of Wockardt (India); these trademarks are individually insignifi- cant and the India CGU to which they are allocated is subject to an overall impairment test. The “Other Intangible assets incl. Products - Proprietary” column mainly includes intangible assets pertaining to the following items as of December 31, 2020: products/ proprietary and other intangible assets valued globally at the purchase of Clarion at €9,802,000, • products/proprietary and valued at the purchase of the Bioniche ® animal health division at €9,250,000 (2019: €11,271,000), • products/proprietary and other intangible assets related to the acquisition of Drontal ® and Profender ® , valued at €110.9 million as of December 31, 2020, • remaining products/proprietary valued at €11,707,000 (2019: €3,933,000).